Edition:
United Kingdom

People: Cara Therapeutics Inc (CARA.OQ)

CARA.OQ on NASDAQ Stock Exchange Global Market

19.96USD
18 Oct 2018
Change (% chg)

$-0.41 (-2.01%)
Prev Close
$20.37
Open
$20.36
Day's High
$20.49
Day's Low
$19.65
Volume
102,258
Avg. Vol
272,553
52-wk High
$24.30
52-wk Low
$11.12

Chalmers, Derek 

Dr. Derek Chalmers, Ph.D. serves as a President, Chief Executive Officer and a Director at Cara Therapeutics, Inc. Dr. Chalmers has over 24 years’ experience in the biotechnology industry with increasing levels of corporate and business responsibilities. Prior to founding our company, Dr. Chalmers co-founded Arena Pharmaceuticals, Inc. (Nasdaq: ARNA), a drug discovery and development company, and served as its Vice President and Executive Director from June 1997 until May 2004. Dr. Chalmers holds a D.Sc. and Ph.D. in Pharmacology from the University of Glasgow. Dr. Chalmers’ qualifications to sit on our Board of Directors include his leadership, executive, managerial and business experience, historical knowledge of our company and his background and experience in the biotechnology industry, including having been a founder of a prior biotechnology company.

Basic Compensation

Total Annual Compensation, USD 759,700
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 2,761,950
Fiscal Year Total, USD 3,521,650

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --